Having book value of 94, available at 8 PE against 17 Industry PE, and enjoying lower crude oil price, have posted good profit in H1, H2 will be also better than H1. The stock is attractive @ 99-100 price for the medium to long term.
|
Sep '15
|
Mar '15
|
Sep '14
|
Net Sales/Income from operations
|
2098.77
|
2249.02
|
1757.04
|
Other Operating Income
|
8.12
|
8.21
|
3.55
|
Total Income From Operations
|
2106.89
|
2257.23
|
1760.59
|
EXPENDITURE
|
|
|
|
Consumption of Raw Materials
|
1414.48
|
1456.21
|
1162.64
|
Purchase of Traded Goods
|
14.63
|
--
|
--
|
Increase/Decrease in Stocks
|
-9.13
|
11.26
|
-7.62
|
Power & Fuel
|
--
|
--
|
--
|
Employees Cost
|
68.6
|
71.19
|
56.49
|
Depreciation
|
89.99
|
79.91
|
64.93
|
Excise Duty
|
--
|
--
|
--
|
Admin. And Selling Expenses
|
--
|
--
|
--
|
R & D Expenses
|
--
|
--
|
--
|
Provisions And Contingencies
|
--
|
--
|
--
|
Exp. Capitalised
|
--
|
--
|
--
|
Other Expenses
|
196.58
|
177.84
|
178.34
|
P/L Before Other Inc. , Int., Excpt. Items &
Tax
|
331.75
|
460.83
|
305.81
|
Other Income
|
45.53
|
73.32
|
27.11
|
P/L Before Int., Excpt. Items & Tax
|
377.28
|
534.15
|
332.92
|
Interest
|
112.62
|
114.23
|
114.3
|
P/L Before Exceptional Items & Tax
|
264.66
|
419.92
|
218.62
|
Exceptional Items
|
-5.68
|
-12.55
|
-9.24
|
P/L Before Tax
|
258.98
|
407.36
|
209.38
|
Tax
|
73.6
|
91.67
|
67.55
|
P/L After Tax from Ordinary Activities
|
185.38
|
315.69
|
141.83
|
Prior Year Adjustments
|
--
|
--
|
--
|
Extra Ordinary Items
|
--
|
--
|
--
|
Net Profit/(Loss) For the Period
|
185.38
|
315.69
|
141.83
|
Equity Share Capital
|
44.46
|
42.44
|
35.51
|
Reserves Excluding Revaluation Reserves
|
--
|
--
|
--
|
Equity Dividend Rate (%)
|
--
|
--
|
--
|
EPS Before Extra Ordinary
|
|
|
|
Basic EPS
|
4.24
|
--
|
4.3
|
Diluted EPS
|
4.2
|
--
|
4.14
|
Biocon/Mylan launch Semglee in UK.
ReplyDeleteequitytips